Referências
Principais artigos
Boxer LA, Newberger PE. A molecular classification of congenital neutropenia syndromes. Pediatr Blood Cancer. 2007 Oct 15;49(5):609-14.Texto completo Resumo
Cham B, Bonilla MA, Winkelstein J. Neutropenia associated with primary immunodeficiency syndromes. Semin Hematol. 2002 Apr;39(2):107-12. Resumo
Taplitz RA, Kennedy EB, Bow EJ, et al. Outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America clinical practice guideline update. J Clin Oncol. 2018 May 10;36(14):1443-53.Texto completo Resumo
Artigos de referência
1. Dale DC, Welte K. Neutrophenia and neutrophilia. In: Kaushansky K, Prchal JT, Burns LJ, et al, eds. Williams hematology. 10th ed. New York, NY: McGraw-Hill; 2021Texto completo
2. Lichtman MA. Classification and clinical manifestations of neutrophil disorders. In: Kaushansky K, Prchal JT, Burns LJ, et al, eds. Williams hematology. 10th ed. New York, NY: McGraw-Hill; 2021.Texto completo
3. Newburger PE, Dale DC. Evaluation and management of patients with isolated neutropenia. Semin Hematol. 2013 Jul;50(3):198-206.Texto completo Resumo
4. Dallman PR. Reference ranges for leukocyte counts in children. In: Nathan DG, Orkin SH, eds. Nathan and Oski's hematology of infancy and childhood. 5th ed. Philadelphia, PA: WB Saunders; 1998.
5. Atallah-Yunes SA, Ready A, Newburger PE. Benign ethnic neutropenia. Blood Rev. 2019 Sep;37:100586.Texto completo Resumo
6. Hsieh MM, Everhart JE, Byrd-Holt DD, et al. Prevalence of neutropenia in the U.S. population: age, sex, smoking status, and ethnic differences. Ann Intern Med. 2007 Apr 3;146(7):486-92.Texto completo Resumo
7. Orfanakis NG, Ostlund RE, Bishop CR, et al. Normal blood leukocyte concentration values. Am J Clin Pathol. 1970 May;53(5):647-51. Resumo
8. Reed WW, Diehl LF. Leukopenia, neutropenia, and reduced hemoglobin levels in healthy American blacks. Arch Intern Med. 1991 Mar;151(3):501-5. Resumo
9. Shoenfeld Y, Alkan ML, Asaly A, et al. Benign familial leukopenia and neutropenia in different ethnic groups. Eur J Haematol. 1988 Sep;41(3):273-7. Resumo
10. Andres E, Federici L, Weitten T, et al. Recognition and management of drug-induced blood cytopenias: the example of drug-induced acute neutropenia and agranulocytosis. Expert Opin Drug Saf. 2008 Jul;7(4):481-9. Resumo
11. Lorenzo-Villalba N, Alonso-Ortiz MB, Maouche Y, et al. Idiosyncratic drug-induced neutropenia and agranulocytosis in elderly patients. J Clin Med. 2020 Jun 10;9(6):1808.Texto completo Resumo
12. Andres E, Maloisel F. Idiosyncratic drug-induced agranulocytosis or acute neutropenia. Curr Opin Hematol. 2008 Jan;15(1):15-21. Resumo
13. Boccia R, Glaspy J, Crawford J, et al. Chemotherapy-induced neutropenia and febrile neutropenia in the US: a beast of burden that needs to be tamed? Oncologist. 2022 Aug 5;27(8):625-36.Texto completo Resumo
14. Berliner N, Horwitz M, Loughran TP Jr. Congenital and acquired neutropenia. Hematology Am Soc Hematol Educ Program. 2004:63-79.Texto completo Resumo
15. Carmona-Bayonas A, Jimenez-Fonseca P, de Castro EM, et al. SEOM clinical practice guideline: management and prevention of febrile neutropenia in adults with solid tumors (2018). Clin Transl Oncol. 2019 Jan;21(1):75-86.Texto completo Resumo
16. Wolach O, Bairey O, Lahav M, et al. Late-onset neutropenia after rituximab treatment: case series and comprehensive review of the literature. Medicine (Baltimore). 2010 Sep;89(5):308-18. Resumo
17. Andersohn F, Konzen C, Garbe E. Systematic review: Agranulocytosis induced by nonchemotherapy drugs. Ann Intern Med. 2007 May 1;146(9):657-65. Resumo
18. Theophile H, Begaud B, Martin K., et al. Incidence of agranulocytosis in Southwest France. Eur J Epidemiol. 2004;19(6):563-5. Resumo
19. van der Klauw MM, Goudsmit R, Halie MR, et al. A population-based case-cohort study of drug-associated agranulocytosis. Arch Intern Med. 1999 Feb 22;159(4):369-74. Resumo
20. Andres E, Maloisel F, Kurtz JE, et al. Modern management of non-chemotherapy drug-induced agranulocytosis: a monocentric cohort study of 90 cases and review of the literature. Eur J Intern Med. 2002 Aug;13(5):324-8. Resumo
21. Salama A, Schutz B, Kiefel V, et al. Immune-mediated agranulocytosis related to drugs and their metabolites: mode of sensitization and heterogeneity of antibodies. Br J Haematol. 1989 Jun;72(2):127-32. Resumo
22. Murphy MF, Chapman JF, Metcalfe P, et al. Antibiotic-induced neutropenia. Lancet. 1985 Dec 7;2(8467):1306-7. Resumo
23. Bhatt V, Saleem A. Review: Drug-induced neutropenia - pathophysiology, clinical features, and management. Ann Clin Lab Sci. 2004 Spring;34(2):131-7.Texto completo Resumo
24. Schwartzberg LS. Neutropenia: etiology and pathogenesis. Clin Cornerstone. 2006;8 (Suppl 5):S5-11. Resumo
25. Capsoni F, Sarzi-Puttini P, Zanella A. Primary and secondary autoimmune neutropenia. Arthritis Res Ther. 2005;7(5):208-14.Texto completo Resumo
26. Klein C, Grudzien M, Appaswamy G, et al. HAX1 deficiency causes autosomal recessive severe congenital neutropenia (Kostmann disease). Nat Genet. 2007 Jan;39(1):86-92. Resumo
27. Bonilla MA, Dale D, Zeidler C, et al. Long-term safety of treatment with recombinant human granulocyte colony-stimulating factor (r-metHuG-CSF) in patients with severe congenital neutropenias. Br J Haematol. 1994 Dec;88(4):723-30. Resumo
28. Freedman MH. Safety of long-term administration of granulocyte colony-stimulating factor for severe chronic neutropenia. Curr Opin Hematol. 1997 May;4(3):217-24. Resumo
29. Welte K, Zeidler C, Dale DC. Severe congenital neutropenia. Semin Hematol. 2006 Jul;43(3):189-95. Resumo
30. Dror Y, Freedman MH. Shwachman-Diamond syndrome: An inherited preleukemic bone marrow failure disorder with aberrant hematopoietic progenitors and faulty marrow microenvironment. Blood. 1999 Nov 1;94(9):3048-54.Texto completo Resumo
31. Boocock GR, Morrison JA, Popovic M, et al. Mutations in SBDS are associated with Shwachman-Diamond syndrome. Nat Genet. 2003 Jan;33(1):97-101. Resumo
32. Son JS, Seo GH, Kim YM, et al. Clinical and genetic features of four patients with pearson syndrome: an observational study. Medicine (Baltimore). 2022 Feb 4;101(5):e28793.Texto completo Resumo
33. Boxer LA, Newberger PE. A molecular classification of congenital neutropenia syndromes. Pediatr Blood Cancer. 2007 Oct 15;49(5):609-14.Texto completo Resumo
34. van Raam BJ, Kuijpers TW. Mitochondrial defects lie at the basis of neutropenia in Barth syndrome. Curr Opin Hematol. 2009 Jan;16(1):14-9. Resumo
35. Ancliff PJ. Congenital neutropenia. Blood Rev. 2003 Dec;17(4):209-16. Resumo
36. Aprikyan AA, Liles WC, Park JR, et al. Myelokathexis, a congenital disorder of severe neutropenia characterized by accelerated apoptosis and defective expression of bcl-x in neutrophil precursors. Blood. 2000 Jan 1;95(1):320-7.Texto completo Resumo
37. Kivitie-Kallio S, Norio R. Cohen syndrome: essential features, natural history, and heterogeneity. Am J Med Genet. 2001 Aug 1;102(2):125-35. Resumo
38. Taban M, Memoracion-Peralta DS, Wang H, et al. Cohen syndrome: report of nine cases and review of the literature, with emphasis on ophthalmic features. J AAPOS. 2007 Oct;11(5):431-7. Resumo
39. Cham B, Bonilla MA, Winkelstein J. Neutropenia associated with primary immunodeficiency syndromes. Semin Hematol. 2002 Apr;39(2):107-12. Resumo
40. Gorlin RJ, Gelb B, Diaz GA, et al. WHIM syndrome, an autosomal dominant disorder: clinical, hematological, and molecular studies. Am J Med Genet. 2000 Apr 24;91(5):368-76. Resumo
41. Maaloul I, Talmoudi J, Chabchoub I, et al. Chediak-higashi syndrome presenting in accelerated phase: a case report and literature review. Hematol Oncol Stem Cell Ther. 2016 Jun;9(2):71-5.Texto completo Resumo
42. Heinz WJ, Buchheidt D, Christopeit M, et al. Diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients: guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO). Ann Hematol. 2017 Nov;96(11):1775-92.Texto completo Resumo
43. Kochanek M, Schalk E, von Bergwelt-Baildon M, et al. Management of sepsis in neutropenic cancer patients: 2018 guidelines from the Infectious Diseases Working Party (AGIHO) and Intensive Care Working Party (iCHOP) of the German Society of Hematology and Medical Oncology (DGHO). Ann Hematol. 2019 May;98(5):1051-69. Resumo
44. Clarke RT, Jenyon T, van Hamel Parsons V, et al. Neutropenic sepsis: management and complications. Clin Med (Lond). 2013 Apr;13(2):185-7.Texto completo
45. Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016 Feb 23;315(8):801-10.Texto completo Resumo
46. National Institute for Health and Care Excellence. Sepsis: recognition, diagnosis and early management. Mar 2024 [internet publication].Texto completo
47. Evans L, Rhodes A, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Crit Care Med. 2021 Nov 1;49(11):e1063-143.Texto completo
48. Royal College of Physicians. National Early Warning Score (NEWS) 2. Dec 2017 [internet publication].Texto completo
49. American College of Emergency Physicians (ACEP) Expert Panel on Sepsis. DART: an evidence-driven tool to guide the early recognition and treatment of sepsis and septic shock. [internet publication].Texto completo
50. Academy of Medical Royal Colleges. Statement on the initial antimicrobial treatment of sepsis. May 2022 [internet publication].Texto completo
51. Schlapbach LJ, Watson RS, Sorce LR, et al. International consensus criteria for pediatric sepsis and septic shock. JAMA. 2024 Feb 27;331(8):665-74.Texto completo Resumo
52. Surviving Sepsis Campaign. Hour-1 bundle: initial resuscitation for sepsis and septic shock. 2019 [internet publication].Texto completo
53. James RM, Kinsey SE. The investigation and management of chronic neutropenia in children. Arch Dis Child. 2006 Oct;91(10):852-8.Texto completo Resumo
54. Newburger PE. Disorders of neutrophil number and function. Hematology Am Soc Hematol Educ Program. 2006:104-10. Resumo
55. Zeidler C, Welte K. Kostmann syndrome and severe congenital neutropenia. Semin Hematol. 2002 Apr;39(2):82-8. Resumo
56. Taplitz RA, Kennedy EB, Bow EJ, et al. Outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America clinical practice guideline update. J Clin Oncol. 2018 May 10;36(14):1443-53.Texto completo Resumo
57. Link DC, Wun T. Myeloid disorders. In: Kahn MJ, Gregory SA, eds. American Society of Hematology Self-Assessment Program. 3rd ed. Washington, DC: American Society of Hematology; 2007.
58. Rogers CL, Bain BJ, Garg M, et al. British Society for Haematology guidelines for the laboratory diagnosis of malaria. Br J Haematol. 2022 May;197(3):271-82.Texto completo Resumo
59. World Health Organization. WHO Guidelines for malaria. Oct 2023 [internet publication].Texto completo
60. Phillips RS, Wade R, Lehrnbecher T, et al. Systematic review and meta-analysis of the value of initial biomarkers in predicting adverse outcome in febrile neutropenic episodes in children and young people with cancer. BMC Med. 2012 Jan 18;10:6.Texto completo Resumo
61. Haeusler GM, Thursky KA, Slavin MA, et al. Risk stratification in children with cancer and febrile neutropenia: A national, prospective, multicentre validation of nine clinical decision rules. EClinicalMedicine. 2020 Jan;18:100220.Texto completo Resumo
62. American College of Medical Genetics. Newborn screening ACT sheets and algorithms. August 2014 [internet publication].Texto completo
63. Biggs HM, Behravesh CB, Bradley KK, et al. Diagnosis and management of tickborne rickettsial diseases: rocky mountain spotted fever and other spotted fever group rickettsioses, ehrlichioses, and anaplasmosis - United States. MMWR Recomm Rep. 2016 May 13;65(2):1-44. Resumo
64. Pattanasin S, Proux S, Chompasuk D, et al. Evaluation of a new plasmodium lactate dehydrogenase assay (OptiMAL-IT) for the detection of malaria. Trans R Soc Trop Med Hyg. 2003 Nov-Dec;97(6):672-4.Texto completo Resumo
65. Ashley EA, Touabi M, Ahrer M, et al. Evaluation of three parasite lactate dehydrogenase-based rapid diagnostic tests for the diagnosis of falciparum and vivax malaria. Malar J. 2009 Oct 27;8:241.Texto completo Resumo
66. Yerlikaya S, Campillo A, Gonzalez IJ. A systematic review: performance of rapid diagnostic tests for the detection of plasmodium knowlesi, plasmodium malariae, and plasmodium ovale monoinfections in human blood. J Infect Dis. 2018 Jun 20;218(2):265-76.Texto completo Resumo
67. Stauffer WM, Cartwright CP, Olson DA, et al. Diagnostic performance of rapid diagnostic tests versus blood smears for malaria in US clinical practice. Clin Infect Dis. 2009 Sep 15;49(6):908-13.Texto completo Resumo
68. Nicastri E, Bevilacqua N, Sañé Schepisi M, et al. Accuracy of malaria diagnosis by microscopy, rapid diagnostic test, and PCR methods and evidence of antimalarial overprescription in non-severe febrile patients in two Tanzanian hospitals. Am J Trop Med Hyg. 2009 May;80(5):712-7. Resumo
69. Chappuis F, Sundar S, Hailu A, et al. Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? Nat Rev Microbiol. 2007 Nov;5(11):873-82.Texto completo Resumo
70. Cota GF, de Sousa MR, Demarqui FN, et al. The diagnostic accuracy of serologic and molecular methods for detecting visceral leishmaniasis in HIV infected patients: meta-analysis. PLoS Negl Trop Dis. 2012;6(5):e1665.Texto completo Resumo
O uso deste conteúdo está sujeito ao nosso aviso legal